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Health care reform has been the primary focus of policymakers for much of the past year, 
culminating with the Patient Protection and Affordable Care Act that was signed into law by 
President Obama on March 23, 2010. The vigorous national debate on the act has highlighted 
the importance of innovative, high-quality research on health and health care policy. 
The New Perspectives on Health and 
Health Care Policy Conference, held on 
March 22 and 23, 2010, at the Federal 
Reserve Bank of Chicago and cospon-
sored by the Chicago Fed and the Institute 
of Government and Public Affairs at the 
University of Illinois, featured presenta-
tions of the latest academic research in 
health policy. This Chicago Fed Letter dis-
cusses the conference and summarizes 
the presentations. 
Impact of Medicare
The conference opened with a historical 
analysis of the effects of the introduction 
of Medicare in 1965. Kenneth Chay of 
Brown University presented new research 
showing that Medicare led to dramatic 
improvements in access to health care 
and reductions in mortality among the 
elderly in the years following its enact-
ment. Chay utilized newly available data 
that enabled him to investigate age-
specific insurance coverage rates both 
prior to and after Medicare’s enactment. 
Using data from 1963 onward, Chay esti-
mates that Medicare caused hospital and 
surgical insurance rates for those 65 and 
older to increase by more than 20%.
Chay also found strong evidence that 
Medicare increased hospital utilization 
and decreased mortality among the elder-
ly. The sharpest mortality reductions were 
in acute causes of death, such as heart 
disease. He estimated that the cost of 
Medicare’s introduction per each addi-
tional patient life-year was less than $200 
(1982–84 dollars). As we continue to 
debate expanding or contracting the 
Medicare program, Chay’s work suggests 
we need to better understand why the 
program was so successful at its inception. 
Competitiveness of health insurance 
markets
Three conference presentations focused 
on the competitiveness of the health 
insurance industry. The first one, by 
Leemore Dafny of Northwestern  
University, explored mergers of health 
insurance companies over the past decade 
and the impact of consolidation on the 
health insurance market. 
The past decade has seen sharp increases 
in both health insurance premiums and 
the level of consolidation within the 
health insurance industry. Dafny noted 
that between 1998 and 2006, average 
health insurance market concentration 
across local markets, as measured by the 
widely used Herfindahl–Hirschman 
Index, increased by 31%. Meanwhile, 
growth in health insurance premiums 
has far exceeded both inflation and 
growth in workers’ earnings. 
Despite these trends, it is not clear wheth-
er there is a causal relationship between 
industry concentration and premiums. 
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be anti-competitive if greater market pow-
er allows insurers to raise premiums. Con-
versely, mergers may be pro-competitive 
and lead to lower premiums if they gen-
erate efficiencies. This could arise from 
improved management, superior distri-
bution systems, or increased investment 
in technology, for example. 
Dafny’s research focused on the Aetna–
Prudential merger of 1999. Aetna and 
Prudential had market shares that varied 
significantly across many local markets, 
allowing Dafny to identify the causal effect 
of consolidation by comparing markets 
that became significantly more concen-
trated as a result of the merger with those 
that experienced only small increases. 
Using data on premiums paid by ten 
million Americans between 1998 and 
2006, she estimated that premiums rose 
about 3% overall as a result of the rise in 
industry concentration. Dafny empha-
sized that this increase, although signif-
icant, is a small fraction of the overall 
increase in premiums during this time. 
Dafny’s study also provided evidence that 
health insurers in more concentrated 
markets exercise monopsonistic power.1 
In a heavily concentrated market, a sin-
gle insurer is likely to exercise control 
over reimbursement rates of health care 
workers, potentially leading to sub-
optimal provision of care. Dafny’s results 
confirmed that in more consolidated 
markets, both physician earnings and 
physician employment are reduced 
while nurse earnings increase.
James Hilliard of the University of Georgia 
used a complementary approach to study 
the effects of consolidation in the insur-
ance market. He examined whether 
rising concentration affects the stock 
market performance of rival insurers 
operating in the same markets. Hilliard’s 
hypothesis was that as the health care 
industry consolidates, rival firms benefit 
from the increased market concentration, 
which increases their expected returns. 
Using data on 36 mergers between 1999 
and 2007, Hilliard found that rivals’ stock 
prices rose after a merger announcement, 
and the effect was more pronounced for 
mergers among larger firms. Like Dafny’s 
results, Hilliard’s evidence also points 
to an anti-competitive effect of mergers. 
The final presenter on this topic, Mark 
Votruba of Case Western Reserve  
University, analyzed how “search fric-
tions”—difficulties in finding an appropri-
ate health plan—affect health insurance 
markets. Many factors make it difficult 
for employers who provide insurance 
to their employees to shop for health 
insurance plans, including the types of 
drugs covered, which physicians are part 
of the provider networks, and the struc-
ture of co-payments, fees, and deduct-
ibles for various providers and services. 
Votruba developed a theoretical model 
in which search frictions give insurers 
market power, allowing them to raise 
premiums. This in turn leads to three 
undesirable results. First, identical insur-
ance products are available at different 
prices in different markets. Second, in-
surance turnover is high, as employers 
have difficulty initially shopping for the 
best product. Increased turnover is es-
pecially harmful as it reduces insurers’ 
incentives to invest in the future health 
of policy holders, reducing preventive 
care and disease management. Third, 
insurers have a strong incentive to engage 
in excessive marketing. 
Votruba found direct empirical evidence 
that search frictions lead to inefficiencies 
by comparing the prices of insurance for 
self-insured groups with those of fully 
insured groups. Since self-insured groups 
mostly search for administration services, 
they would be expected to encounter less 
search friction than fully insured groups. 
Votruba found that there was greater dis-
persion in prices for fully insured groups 
than for self-insured groups. Further, he 
estimated that search frictions transfer 
13% of consumer surplus from employ-
ers to insurers and increase employer 
group turnover by 64% for the average 
insurance policy. 
Panel discussion on health care policy
The conference featured presentations 
on health care policy by two of the coun-
try’s leading health care experts, David 
Cutler of Harvard University and Mark 
Pauly of the University of Pennsylvania. 
Both presenters focused their remarks 
on the new federal legislation. Cutler, 
who was previously on the Council of 
Economic Advisors and the National 
Economic Council and advised the 
presidential campaigns of Bill Bradley, 
John Kerry, and Barack Obama, said that 
the health care reform act is important 
because it will expand coverage and im-
prove the value of health care. He argued 
that the health care industry can improve 
itself by implementing organizational 
changes that focus on better use of in-
formation technology, engaging workers 
and consumers in continuous quality im-
provements, and creating compensation 
arrangements that reward value. He also 
noted that the act will begin evaluations 
of several cost-saving ideas to determine 
which will be most effective, including 
transitional care and bundled payments 
for care from different providers.
Pauly has consulted for the Department 
of Health and Human Services and served 
on the Medicare Technical Advisory 
Board and on the National Institutes of 
Health National Advisory Committee. 
He argued that expanding coverage 
should be the sole focus of health care 
reform. He said he did not believe it was 
possible to increase the quantity and qual-
ity of care and lower costs at the same 
time. Expanding coverage, he argued, 
has positive health benefits for the un-
insured and helps in the prevention of 
communicable disease. 
Pauly pointed to a few challenges the 
act presents. It will not slow the rate of 
growth of health care costs, he con-
tended, as both demand for improved 
technology and the wages of health care 
workers continue to rise. Among meth-
ods for cutting costs, he said he preferred 
capping the tax exclusion for employer-
based health coverage, as it would raise 
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workers to over-consume health care. 
Since the impact of the act on costs is 
uncertain, Pauly said he favored the in-
clusion of better rules for making future 
adjustments so that the act’s initial im-
pact can be observed. 
Changing behavior to reduce costs
Recently, employer wellness incentive-
based programs have become popular 
as a way for companies to improve em-
ployee health and reduce health care 
costs. Heather Royer of the University 
of California, Santa Barbara, and Karen 
Norberg of Washington University in 
St. Louis presented new research that 
finds that these programs can improve 
individual health behaviors and outcomes.
Royer conducted a randomized field ex-
periment at a Fortune 500 company to 
study employee exercise habits. Individ-
uals were assigned to one of three groups. 
The first group was a control group. The 
second group received a financial incen-
tive of $10 per visit to the company gym 
for up to three visits per week for up to 
four weeks. The third group received 
the same incentive and, after the four 
weeks, they were invited to complete a 
commitment contract that required them 
to forfeit their earned money if they did 
not continue regular exercise.
Royer found that both the financial in-
centive group and the commitment con-
tract group had higher exercise levels 
during the first four weeks, with the com-
mitment contract group having the high-
est levels. The commitment contract 
group’s higher exercise levels persisted 
beyond the first four weeks. These effects 
existed for both non-gym members, who 
may not have been exercising regularly 
before the experiment, and gym mem-
bers, who were more likely to have been 
exercising regularly. In future work, Royer 
plans to examine the impact on partic-
ipants’ health and the cost effectiveness 
of the program.
Norberg examined the results of an in-
surance-based wellness intervention. In 
2004, a hospital introduced a smoking 
cessation program for its employees. One 
year later, this hospital introduced a larg-
er program that offered a generous health 
plan for employees who signed a health 
pledge, provided health measures annu-
ally, and enrolled in a smoking cessation 
program if necessary. The program health 
plan offered an extra annual employer 
contribution that was up to $1,647 more 
than what was offered under the non-
program health plan.
Using claims data from 2003 through 
2006, Norberg compared 30,212 enrollees 
per month at the hospital with the inter-
vention with 31,567 enrollees per month 
at two other area employers without the 
intervention. The program reduced hos-
pitalization for targeted conditions, in-
cluding diabetes and heart disease, by 
31% and reduced all hospitalizations 
by 12%. Prescriptions filled were also 
reduced significantly.
Comparative effectiveness research
Comparative effectiveness research (CER) 
aims to assess the efficacy and costs of 
alternative medical treatments. It has 
emerged as a critical topic in health care 
policy and is potentially an important 
way to improve the efficiency of health 
care spending. 
Tomas Philipson of the University of 
Chicago argued that it is important to 
understand the market and government 
response to CER in order to understand 
CER’s impact. He emphasized that CER 
often results in one treatment being 
deemed superior to all others, without 
accounting for the possibility of het-
erogeneous treatment effects, i.e., that 
different treatments may be best for 
different patients. 
Philipson presented several theoretical 
models of the effects of CER. He showed 
that if there are no heterogeneous treat-
ment effects, then a government subsidy 
for only one treatment will improve the 
overall health of the population. In the 
heterogeneous case, however, it is not 
clear whether overall health would im-
prove. Patients who would respond better 
to the non-subsidized treatment may 
choose the more cheaply available sub-
sidized treatment. In either case, he ar-
gued that overall spending could rise or 
fall, because the fall in spending on the 
non-subsidized treatment may or may 
not be offset by spending increases for 
the subsidized treatment. 
Philipson used a real-world example, a 
1999 trial of antipsychotic drugs, to illus-
trate the potential importance of account-
ing for heterogeneous effects. He found 
that if Medicaid had eliminated coverage 
for the treatments deemed least effective 
and patients were assumed to respond 
homogeneously to treatments, then 
the trial would result in large savings of 
Medicaid class sales in non-elderly adult 
patients with schizophrenia. However, 
accounting for heterogeneity in treat-
ment response, the trial would result in 
a net loss. Philipson argued that CER can 
be beneficial, but care must be taken to 
interpret the results of trials properly 
and take into account patient-specific 
responses in implementing policy.
Another real-world example of CER’s 
impact was provided by David Howard 
of Emory University, who examined the 
response by health care providers to a 
May 1999 American Society of Clinical 
Oncology study of breast cancer treat-
ments. While the use of high-dose chemo-
therapy followed by hematopoietic stem 
cell transplantation (HDC/HCT) had 
been a popular treatment in the 1990s, 
the 1999 randomized control trial found 
the treatment to be entirely ineffective. 
Howard found that while the study re-
sulted in discontinuation of the treat-
ment, the rate of discontinuation was 
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Howard estimated that the trials reduced 
medical spending by about $120 million 
per year. However, the median time for 
hospitals to stop providing HDC/HCT 
was about 15 months. Hospitals with 
greater volumes of HDC/HCT were 
slower to move away from the treatment. 
He also presented evidence that the pat-
tern of discontinuation more closely 
resembled a passive approach than an 
active one, indicating that hospitals were 
motivated to abandon HDC/HCT by a 
fall in treatment demand from patients 
rather than by information about the 
treatment’s ineffectiveness. 
New medical technologies
Laurence Baker of Stanford University 
presented a study of the effect of phy-
sician ownership of MRI equipment on 
health outcomes. Physicians who own 
equipment have a strong financial incen-
tive to use their MRI equipment, rather 
than referring patients to other provid-
ers. This may lead to inefficient overuse 
as physicians use the equipment in cases 
where they would not have otherwise 
done so. Using Medicare claims data 
from 1998 to 2005, Baker compared 
physicians who acquired MRI equipment 
with those who did not and found a 
strong effect of equipment ownership. 
Ownership caused physicians to prescribe 
28 more MRIs per 1,000 patients in the 
first 30 days after acquiring equipment; 
and acquiring equipment increased MRI 
spending by about $1,400 in the first 90 
days. Spending on other complementary 
procedures, such as X-rays, also increased. 
These increases far outweighed the $600 
fall in spending on outpatient procedures 
associated with MRI ownership.
Developmental origins of health
Nobel Laureate James Heckman of the 
University of Chicago concluded the con-
ference with a keynote address in which 
he presented a framework for studying 
the effects of policy interventions on 
health over the life cycle. He presented 
evidence that a number of factors con-
tribute to overall health and wellness, 
emphasizing the importance of both 
cognitive and non-cognitive skills and 
synergies between different interventions. 
Heckman used longitudinal data from 
the British Cohort Study of 1970, from 
which he could observe people at birth, 
age ten, and age 30, to study the impact 
of education on health. He compared 
health outcomes at 30 of those who had 
education beyond the compulsory level 
in Britain with health outcomes of those 
who had only the compulsory level of 
education. He found that education 
significantly affected health, and the effects 
were strongest for those with low non-
cognitive ability and those with high 
cognitive ability. However, the effect of 
education could only account for part 
of the observed differences in health 
outcomes at age 30. One’s cognitive and 
non-cognitive skills and health at age ten 
(which are of course unaffected by later 
education) explained as much as half 
of the difference in physical and mental 
health outcomes at age 30. Heckman’s 
work demonstrates the importance of 
development in the early years for health 
and well-being throughout one’s lifetime.
Conclusion
The New Perspectives on Health and 
Health Care Policy Conference produced 
fruitful discussion on a variety of impor-
tant topics. A common theme across the 
sessions was that new and innovative 
methodological approaches have yielded 
interesting and often nuanced findings 
that can inform policymakers. The re-
search presented at the conference also 
serves as a stepping stone to further work 
that will help guide efforts to improve 
the health care system.
1  Monopsonistic power refers to cases where 
a single buyer controls a large share of the 
market. This is sometimes the case when there 
is a single employer in a geographic area.